G Hölzemann1, A Löw, J Harting
1Medical Chemistry Research Department, E. Merck, Darmstadt, Germany.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers synthesized novel cyclic hexapeptides, some with carbohydrate side chains, demonstrating selective NK-2 receptor antagonism. These compounds show promising binding affinities, highlighting the potential for diverse side chain accommodation without activity loss.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: